GENE ONLINE|News &
Opinion
Blog

Imara Inc.
Trials & Approvals Sickle Cell Disease
Imara’s Sickle Cell Disease Therapy Impresses in Phase 2 Trial
2021-01-09
LATEST
Investor Trust and Market Timing Shape the New IPO Playbook
2025-06-18
Eli Lilly Acquires SiteOne Therapeutics to Develop Non-Opioid Pain Treatment STC-004
2025-06-18
New Device Promises to Streamline CAR T-Cell Therapy Production for Earlier Cancer Treatment
2025-06-18
Roche Reports Near-Complete Suppression of Disability Progression in RMS Patients Over Two Years with BTK Inhibitor
2025-06-18
Technological Advancements Reduce R&D Costs and Propel Growth of Cell and Gene Therapies in Biopharmaceutical Sector
2025-06-18
Orlando Sales Firm Seeks Pharmaceutical Sales Professionals for Entry-Level Roles in Alafaya
2025-06-18
AstraZeneca Hiring Primary Care Pharmaceutical Sales Specialists for National Sales Network in US
2025-06-18
READ MORE
EVENT
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top